| Record ID | marc_columbia/Columbia-extract-20221130-012.mrc:60659750:3338 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-012.mrc:60659750:3338?format=raw |
LEADER: 03338cam a22004094a 4500
001 5569503
005 20221121183857.0
008 050809t20052005nyua b 001 0 eng
010 $a 2005023226
016 7 $a101254787$2DNLM
020 $a1588904008 (TMP : alk. paper)
020 $a3131417315 (GTV : alk. paper)
024 3 $a9781588904003
024 3 $a9783131417312
029 1 $aNLM$b101254787
035 $a(OCoLC)ocm61295836
035 $a(NNC)5569503
035 $a5569503
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dC#P$dOrLoB-B
042 $apcc
050 00 $aRC78.7.T62$bL56 2005
060 10 $aWN 206$bL735p 2005
082 00 $a616.07/57$222
100 1 $aLin, Eugene.$0http://id.loc.gov/authorities/names/n2005183351
245 10 $aPET and PET/CT :$ba clinical guide /$cEugene Lin, Abass Alavi.
260 $aNew York, NY :$bThieme Medical Publishers,$c[2005], ©2005.
300 $aviii, 190 pages :$billustrations (some color) ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tThe physics of PET/CT scanners /$rRuth Schmitz, Adam Alessio and Paul Kinahan -- $g2.$tBasics of fluorodeoxyglucose radiochemistry and biology /$rN. Scott Mason and Eugene C. Lin -- $g3.$tPatient preparation /$rEugene C. Lin and Abass Alavi -- $g4.$tStandardized uptake value /$rEugene C. Lin, Abass Alavi and Paul Kinahan -- $g5.$tNormal variants and benign findings /$rEugene C. Lin, Abass Alavi and Edgar Cheng -- $g6.$tInterpretation of FDG pet studies /$rEugene C. Lin and Abass Alavi -- $g7.$tPET/CT /$rEugene C. Lin, Abass Alavi, Paul Kinahan and Edgar Cheng -- $g8.$tKey to clinical indications /$rEugene C. Lin -- $g9.$tOncological PET by anatomical region /$rEugene C. Lin and Abass Alavi -- $g10.$tTherapy response /$rEugene C. Lin -- $g11.$tBrain neoplasms /$rEugene C. Lin and Abass Alavi -- $g12.$tHead and neck cancer /$rEugene C. Lin and Abass Alavi -- $g13.$tThyroid cancer /$rEugene C. Lin and Abass Alavi -- $g14.$tThoracic neoplasms /$rEugene C. Lin and Abass Alavi -- $g15.$tBreast cancer /$rEugene C. Lin, Abass Alavi and Marie Lee -- $g16.$tGastric and esophageal cancer /$rEugene C. Lin and Abass Alavi -- $g17.$tLymphoma /$rEugene C. Lin and Abass Alavi -- $g18.$tMelanoma /$rEugene C. Lin and Abass Alavi -- $g19.$tHepatobililiary neoplasms /$rEugene C. Lin and Abass Alavi -- $g20.$tPancreatic cancer /$rEugene C. Lin and Abass Alavi -- $g21.$tGynecological tumors /$rEugene C. Lin and Abass Alavi -- $g22.$tUrological neoplasms /$rEugene C. Lin and Abass Alavi -- $g23.$tColorectal cancer /$rEugene C. Lin, Abass Alavi and Edgar Cheng -- $g24.$tMusculoskeletal tumors /$rEugene C. Lin and Abass Alavi -- $g25.$tMyocardial viability /$rAmol Takalkar, Luis Araujo and Eugene C. Lin -- $g26.$tNeurological applications /$rEugene C. Lin and Abass Alavi.
650 0 $aTomography, Emission.$0http://id.loc.gov/authorities/subjects/sh85135956
650 12 $aPositron-Emission Tomography$xmethods.$0https://id.nlm.nih.gov/mesh/D049268Q000379
650 22 $aFluorodeoxyglucose F18$xdiagnostic use.
700 1 $aAlavi, Abass.$0http://id.loc.gov/authorities/names/n80127237
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/ecip0517/2005023226.html
852 00 $boff,hsl$hRC78.7.T62$iL56 2005